J. Delabie et al., CONCURRENT LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE AND T-CELL LYMPHOMA - A REPORT OF 3 CASES, The American journal of surgical pathology, 20(3), 1996, pp. 355-362
Lymphocyte predominance Hodgkin's disease (LPHD) is a B-cell lymphopro
liferative disorder; patients with LPHD have an increased risk of deve
loping synchronous or metachronous B-cell non-Hodgkin's lymphoma. The
synchronous presence of LPHD and B-cell lymphoma in the same lymph nod
e in some cases lends support to the argument that the B-cell lymphoma
arises as a consequence of transformation or progression of LPHD. We
have recently identified three cases of LPHD occurring simultaneously
with T-cell lymphoma in a series of 76 cases of LPHD in the files of t
he Nebraska Lymphoma Study Group Registry. In large areas of the lymph
nodes, atypical T cells with large, irregular, and hyperchromatic nuc
lei were admired with Reed-Sternberg variants characteristic of LPHD (
L&H cells). However, in all cases, areas of typical nodular LPHD witho
ut obvious T-cell lymphoma were also evident. In one case, frozen-sect
ion immunohistochemistry demonstrated the absence of expression of CD5
, CD4, or CD8 by the T-cell lymphoma. The L&H cells in all cases expre
ssed CD45 and CD20, as expected. In all three cases, clonal T-cell rec
eptor (TCR)-gamma gene and TCR-beta gene rearrangements were documente
d by polymerase chain reaction analysis and Southern blotting, respect
ively. No clonally rearranged immunoglobulin genes were detected by ei
ther technique. To our knowledge, this represents the first report of
the simultaneous occurrence of LPHD and T-cell lymphoma. Although B-ce
ll lymphoma occurring in the setting of LPHD is a well-recognized phen
omenon, previous reports of T-cell lymphoma occurring after a diagnosi
s of LPHD, as well as our cases with synchronous disease, suggest that
the association of T-cell lymphoma and LPHD may not be uncommon as we
ll. Furthermore, our cases indicate that T-cell lymphoma occurring in
LPHD is not therapy related. However, the underlying mechanisms by whi
ch these composite lymphomas occur remain unknown.